SCHEMBL7813655

SCHEMBL7813655

CC(C)(Oc1cccc(N2CCN(C(=O)c3ccccc3)CC2)c1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.59
LMNA P02545 3/20 0.59
TSHR P16473 3/20 0.59
USP2 O75604 1/20 0.59
MAPK1 P28482 1/20 0.59
POLB P06746 2/20 0.54
ALDH1A1 P00352 3/20 0.54
CRHBP P24387 1/20 0.54
HTT P42858 1/20 0.54
CRHR2 Q13324 1/20 0.54
PARP14 Q460N5 1/20 0.53
PARP10 Q53GL7 1/20 0.53
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
SLC6A7 Q99884 1/20 0.51
NAMPT P43490 1/20 0.50
DRD2 P14416 1/20 0.50
HTR2A P28223 1/20 0.50
ITGB3 P05106 1/20 0.49
ITGA2B P08514 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811727 0.92 PPARG (0.52) MAPTLMNATSHRUSP2MAPK1
SCHEMBL7811529 0.92 ALDH1A1 (0.56) MAPTLMNATSHRUSP2MAPK1
SCHEMBL7810027 0.91 MAPT (0.50) MAPTLMNATSHRUSP2MAPK1
SCHEMBL7814070 0.91 SMN1; SMN2 (0.54) MAPTLMNATSHRUSP2MAPK1
SCHEMBL7811455 0.91 MAPT (0.50) MAPTLMNATSHRUSP2MAPK1
SCHEMBL7804634 0.91 ALDH1A1 (0.60) MAPTLMNATSHRUSP2MAPK1
SCHEMBL7813606 0.91 MAPT (0.58) MAPTLMNATSHRMAPK1ALDH1A1
SCHEMBL7813395 0.89 PPARD (0.53) MAPTLMNATSHRPOLBALDH1A1
SCHEMBL7804420 0.88 ALDH1A1 (0.73) MAPTLMNATSHRUSP2MAPK1
SCHEMBL7811736 0.88 ITGB3 (0.64) MAPTLMNATSHRUSP2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed